A. Horsley (Manchester, United Kingdom), M. Stahl (Berlin, Germany)
Late Breaking Abstract - Use of ultra-low dose CT does not impact structure-function relationships in early Cystic Fibrosis lung disease
K. Bayfield (Sydney, Australia), O. Weinheimer (Heidelberg, Germany), C. Boyton (Sydney, Australia), R. Fitzpatrick (Sydney, Australia), A. Middleton (Sydney, Australia), B. Kennedy (Sydney, Australia), A. Blaxland (Sydney, Australia), G. Jayasuriya (Sydney, Australia), N. Caplain (Sydney, Australia), M. Wielpuetz (Heidelberg, Germany), L. Yu (Minneosota, United States of America), C. Galban (Michigan, United States of America), T. Robinson (Stanford, United States of America), B. Bartholmai (Minneosota, United States of America), P. Gustafsson (Skövde, Sweden), D. Fitzgerald (Sydney, Australia), H. Selvadurai (Sydney, Australia), P. Robinson (Sydney, Australia)
|     |
Lung clearance index and functional MRI outcomes to assess lung disease in preschool children with cystic fibrosis
B. Frauchiger (Bern, Switzerland), C. Willers (Bern, Switzerland), Y. Salem (Bern, Switzerland), P. Latzin (Bern, Switzerland), K. Ramsey (Bern, Switzerland)
| |
Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis
B. Frauchiger (Bern, Switzerland), S. Binggeli (Bern, Switzerland), S. Yammine (Bern, Switzerland), B. Spycher (Bern, Switzerland), K. Ramsey (Bern, Switzerland), P. Latzin (Bern, Switzerland)
| |
Early determinants of lung disease in children with cystic fibrosis
S. Stanojevic (Toronto (ON), Canada), S. Davis (Chapel Hill, United States of America), D. Sanders (Indianapolis, United States of America), L. Perem (Toronto (ON), Canada), M. Shaw (Toronto (ON), Canada), J. Guido (Toronto (ON), Canada), R. Jensen (Toronto (ON), Canada), S. Jara (Indianapolis, United States of America), C. Clem (Toronto (ON), Canada), M. Solomon (Toronto (ON), Canada), N. Sweezey (Toronto (ON), Canada), H. Grasemann (Toronto (ON), Canada), V. Waters (Toronto (ON), Canada), F. Ratjen (Toronto (ON), Canada)
| |
The Lung Clearance Index detects incomplete lung function recovery with acute respiratory events in school-age children with cystic fibrosis
L. Perrem (Toronto (ON), Canada), S. Stanojevic (Toronto (ON), Canada), M. Shaw (Toronto (ON), Canada), R. Jensen (Toronto (ON), Canada), J. Guido (Toronto (ON), Canada), M. Solomon (Toronto (ON), Canada), H. Grasemann (Toronto (ON), Canada), N. Sweezey (Toronto (ON), Canada), S. Davies (North Carolina, United States of America), D. Sanders (Indianapolis, United States of America), N. Mcdonald (Toronto (ON), Canada), S. Isaac (Toronto (ON), United States of America), S. Jara (Indianapolis, United States of America), C. Clem (Indianapolis, United States of America), F. Ratjen (Toronto (ON), Canada)
| |
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
J. Spano (Palo Alto, United States of America), S. Ryan (Palo Alto, United States of America), C. Milla (Palo Alto, United States of America)
| |
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
F. Pennati (Milano (MI), Italy), I. Borzani (Milano (MI), Italy), L. Moroni (Milano (MI), Italy), M. Russo (Milano (MI), Italy), A. Aliverti (Milano (MI), Italy), C. Colombo (Milano (MI), Italy)
| |
Feasibility of unsedated lung MRI in preschoolers with Cystic fibrosis – a comparison to lung function.
C. Willers (Bern, Switzerland), B. Frauchiger (Bern, Switzerland), Y. Salem (Bern, Switzerland), P. Latzin (Bern, Switzerland), K. Ramsey (Bern, Switzerland)
| |